Lab Automation and Bioinformatics News and Research

Latest Lab Automation and Bioinformatics News and Research

Determining the optimal age of stem cells to restore heart tissue

Biophysicists have successfully established the optimal age of reprogrammed stem cells that are appropriate for restoring heart tissues.

27 May 2020

New sequencing method helps map the spatial arrangement of DNA

A sequencing technique helps to map the spatial arrangement of DNA in the cell nucleus, revealing which regions of the genome are at greater risk of mutation.

27 May 2020

Pre-existing genes can promote metastasis

Cancer can sometimes remain dormant, but it usually metastasizes and spreads to new sites in the body.

27 May 2020

New model mimics early embryonic stages of the human brain

We know a lot about the human brain, but very little about how it is formed. In particular, the stages from the second to the seventh week of embryonic development have so far been virtually unknown territory to brain researchers.

26 May 2020

EKF secures COVID-19 novel sample collection kit manufacturing and supply contracts

EKF Diagnostics, the global in vitro diagnostics company, announces it has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows COVID-19 samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration.

From EKF Diagnostics 26 May 2020

Introducing genetic “barcodes” to DNA samples can preserve their integrity

Researchers have developed a technique to ensure that DNA fingerprinting continues to be secure against malicious attacks or mistakes in the field.

25 May 2020

Compounds in Brazilian shrub can reduce the virulence of antibiotic-resistant bacteria

Researchers have discovered that the Brazilian peppertree—an invasive, weedy shrub found in Florida—contains specific compounds that lower the virulence of Staphylococcus bacteria that are resistant to antibiotics.

25 May 2020

Researchers identify the smallest gene to study the evolution of metazoans

St Petersburg University researchers have successfully interpreted the Intoshia variabili gene, which happens to be the smallest representative of the parasite belonging to Orthonectida group.

22 May 2020

Scientists develop novel model of liver cancer stem cells from normal iPSCs

Liver cancer is one of the deadliest cancers. It is insidious and does not present symptoms until it has progressed considerably, at which point, treatment options are limited and chances of survival are low. The most common type of liver cancer is hepatocellular carcinoma.

22 May 2020

Eating Fish Reduces Risk Of Cardiovascular Disease

A study has found that consuming omega 3 primarily through fish, can modulate lipoproteins and can reduce the risk of cardiovascular disease.

22 May 2020

Low-Severity Fires Enhance Long-Term Carbon Retention Of Peatlands

High-intensity fires can destroy peat bogs, causing them to emit carbon, but a new study finds low-severity fires spark the opposite outcome.

22 May 2020

New flow cytometry technique to quantify protein production in T-cells

A team of scientists from Hollings Cancer Center at the Medical University of South Carolina has developed a novel flow cytometry technique that can, for the first-time, quantify protein production in T-cells.

21 May 2020

Innovative tool to speed up the drug discovery process

A better understanding of the interaction between a molecule and the organism is important to consider its therapeutic potential.

21 May 2020

Subcellular chatter plays key role in regulating longevity

As people get older, they often feel less energetic, mobile or active. This may be due in part to a decline in mitochondria, the tiny powerhouses inside of our cells, which provide energy and regulate metabolism.

20 May 2020

X-ray experiments reveal antibody to block entry of SARS-CoV-2

As scientists across the globe race to develop a vaccine against SARS-CoV-2, the coronavirus that causes COVID-19, an international team led by Davide Corti at Vir Biotechnology and David Veesler at the University of Washington has been working around the clock on a complementary approach - identifying neutralizing antibodies that could be used as a preventative treatment or as a post-exposure therapy.

20 May 2020